SRXHConsumer Defensive · Packaged Foods

SRXH Stock Forecast: SRX Global, Inc. Price Predictions for 2026-2027

Last close, 31 July 2026
$1.38

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 2 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap
$26.9M
Ticker Nerd rank
2 / 100
Median analyst target
Analysts covering
Ticker Nerd rank

SRXH stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SRX Global, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
2 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
86
Revisions
25
Momentum
22
Volatility
21
Accruals
8
Quality
3
Value
2
Issuance
2
Growth
1

Size (86): Smaller than most of the companies we track.

Growth (1): Sales and profits are flat, shrinking, or growing more slowly than they were.

The rank is the raw material. Whether the rules would actually own SRX Global, Inc. — and when they’d sell — is the membership.

Wall Street

SRXH stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SRXH, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

SRXH analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

SRX Global, Inc. (SRXH) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.8×

Cheaper than 81% of US stocks

Price / sales
4.1×

Cheaper than 30% of US stocks

Price / book
0.4×

Cheaper than 86% of US stocks

EV / EBITDA
−2.6×

Cheaper than 74% of US stocks

Growth & margins
Revenue growth (YoY)
22.5%

Higher than 74% of US stocks

Earnings growth (YoY)
−52.0%

Higher than 10% of US stocks

Gross margin
37.1%

Higher than 47% of US stocks

Operating margin
−122.6%

Higher than 13% of US stocks

Net margin
23.4%

Higher than 85% of US stocks

Returns & dividend
Return on equity
−11058.0%

Higher than 1% of US stocks

Return on assets
−535.7%

Higher than 1% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

SRXH vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelPackaged Foods
CompanyMarket capTKN rank
SRXHSRX Global, Inc.$26.9M
2
DDCDDC Enterprise Ltd.$20.8M
4
JVACoffee Holding Co., Inc.$19.5M
59
COOTAustralian Oilseeds Holdings Ltd.$17.7M
6
BRLSBorealis Foods, Inc.$16.7M
49
HAINThe Hain Celestial Group, Inc.$45.4M
41
LSFLaird Superfood, Inc.$45.8M
30
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SRXH appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest SRXH news & analysis

SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger

GlobeNewsWire · 3 Aug 2026positive

SRX Global, Inc. (NYSE American: SRXH) announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, will merge with Ferrox Critical Minerals, a move it said strengthens critical minerals sourcing.

Why it matters — The merger involves an SRX portfolio company, so the development could affect the value of SRX's investment portfolio.

SRX Global Acquires Shares in Jersey Mike's $1 Billion Initial Public Offering

GlobeNewsWire · 30 July 2026positive

SRX Global Inc. announced it acquired shares in the initial public offering of Jersey Mike's, a fast-casual restaurant franchisor, which priced at $23.00 per share at a $1 billion valuation and began trading on the NYSE under the ticker JMKE.

Why it matters — SRXH shareholders may view this as an investment by the company into a high-profile IPO, potentially contributing to SRX Global's portfolio of strategic assets.

FAQ

Frequently asked questions about SRXH stock

How does Ticker Nerd's model rank SRXH?

As at 1 Aug 2026, SRX Global, Inc. ranks 2 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (86 of 100).

What is the SRXH stock forecast for 2030?

No analyst covering SRX Global, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SRXH are extrapolating price history, which says nothing about the business.

What does SRX Global, Inc. do?

SRx Health Solutions Inc. is an integrated healthcare services provider specializing in the delivery of comprehensive medical and wellness solutions across Canada.

What is the latest news on SRXH?

The most recent item we track (GlobeNewsWire, 3 Aug 2026): "SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger". SRX Global, Inc. (NYSE American: SRXH) announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK), a leader in advanced materials, will merge with Ferrox Critical Minerals, a move it said strengthens critical minerals sourcing.

Company

About SRX Global, Inc.

SRx Health Solutions Inc. is an integrated healthcare services provider specializing in the delivery of comprehensive medical and wellness solutions across Canada. Established in 2013 and headquartered in Toronto, the company offers a diverse portfolio of healthcare services, including pharmacy operations, compounding services, nursing care, clinic and vaccination services, diabetes management, travel health support, tuberculosis testing, and HIV prevention programs. SRx Health Solutions is recognized for operating both specialty and retail-owned pharmacies and has also delivered services such as COVID-19 testing. Its expansive network spans all ten Canadian provinces, making it one of the country's most accessible providers of customized specialty healthcare services. The company leverages industry expertise, advanced technology, and a patient-centric approach to enhance care quality and drive critical patient wellness initiatives. Following a recent merger, SRx Health Solutions has broadened its impact to serve both people and pets, aiming to set new standards in specialty healthcare and wellness for individuals, families, and companion animals alike.

CEO Dr. Eric M. Jackson Ph.D. · 7 employees · United States · https://www.srxglobalinc.com